Hi, what are you looking for?
Jewish Business News
Search results for "Perrigo "
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.
Business
In the three way takeover battle Mylan is getting nervous.
Business
Three Way Takeover Battle: believes their offer will win approval from Perrigo stockholders.
Business
Teva Pharmaceutical Industries Ltd, an Israeli-based company, has acquired a 1.35 percent stake in Mylan through purchases on the open market, increasing pressure on...
Business
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Business
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
Business
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Business
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...